The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)
NCT07276802
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Post Cataract Surgery
Interventions
DRUG:
Triamcinolone (Optional)
DRUG:
control group
Sponsor
Research Insight LLC